<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02525900</url>
  </required_header>
  <id_info>
    <org_study_id>204411</org_study_id>
    <nct_id>NCT02525900</nct_id>
  </id_info>
  <brief_title>ssTAP vs TAP Catheters in TAH</brief_title>
  <official_title>Comparing the Efficacy of Transversus Abdominis Plane Block, Both Single Injection and Continuous Block Technique, to Wound Infiltration for Total Abdominal Hysterectomy: A Prospective Randomized Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Arkansas</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Arkansas</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prospective, randomized study comparing local wound infiltration with local anesthetic (LA)
      versus single injection TAP blocks (ssTAP) with LA versus continuous TAP block (TAP caths)
      catheters with LA for treatment of postoperative pain after total abdominal hysterectomy
      (TAH).
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2016</start_date>
  <completion_date type="Anticipated">April 2018</completion_date>
  <primary_completion_date type="Anticipated">April 2018</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Total morphine consumption postoperatively for pain management as measured by the Visual Analog Scale (VAS) pain scale.</measure>
    <time_frame>Up to 48 hours post treatment</time_frame>
    <description>The total morphine consumption used post operatively to manage pain will be measured utilizing the VAS pain scale with 0 being no pain and 10 being as much pain as can be tolerated.</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Postoperative Pain</condition>
  <arm_group>
    <arm_group_label>Wound Infiltration</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>0.5mg/kg of 0.25% bupivacaine will be injected around the incision for wound infiltration</description>
  </arm_group>
  <arm_group>
    <arm_group_label>TAP Blocks</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>20mL of 0.25% bupivacaine will be injected on each side of the abdomen for ssTAP procedures</description>
  </arm_group>
  <arm_group>
    <arm_group_label>TAP Catheters</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>20mL of 0.25% bupivacaine will be injection on each side of the abdomen and catheters placed for repeat bolus every 12 hours with 20mL of 0.25% Bupivacine until 48 hours post procedure or hospital discharge.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Wound Infiltration with 0.25% Bupivacine</intervention_name>
    <arm_group_label>Wound Infiltration</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>bilateral TAP block with 0.25% Bupivacaine</intervention_name>
    <arm_group_label>TAP Blocks</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>bilateral TAP Catheter with repeat bolus of 0.25% Bupivacaine</intervention_name>
    <arm_group_label>TAP Catheters</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Scheduled to undergo total abdominal hysterectomy

          -  Age ≥ 18 years.

          -  American Society of Anesthesiologists (ASA) physical status ≤ 3

        Exclusion Criteria:

          -  Known coagulopathy

          -  Known allergy to Bupivacaine or morphine

          -  Contraindication to Tylenol usage

          -  Medical conditions contraindicated to bupivacaine use

          -  Daily narcotic usage for ≥ 2 weeks of 20mg of oxycodone daily or an equivalent.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sarah Tingle, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Arkansas</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sarah Tingle, M.D.</last_name>
    <phone>501.686.6114</phone>
    <email>stingle@uams.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Arkansas for Medical Sciences</name>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <zip>72205</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sarah K Tingle, MD</last_name>
      <phone>501-317-7477</phone>
      <email>stingle@uams.edu</email>
    </contact>
    <contact_backup>
      <last_name>Gregory Mehaffey, MD</last_name>
      <email>gmehaffey@uams.edu</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 14, 2015</study_first_submitted>
  <study_first_submitted_qc>August 14, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 18, 2015</study_first_posted>
  <last_update_submitted>July 18, 2017</last_update_submitted>
  <last_update_submitted_qc>July 18, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 21, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

